Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05678738 · ClinicalTrials.gov registry record · NA
Acquiring and Targeting Heat Exposures Necessary for Action
A NA study of Heat Stress and Fatigue; Heat, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT05678738 is a NA study of Heat Stress and Fatigue; Heat that has completed, run by University of Connecticut. The registered enrollment target is 108 participants, above the 47-participant average among 5 other Heat Stress trials with a reported enrollment target (130% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05678738, a NA study of Heat Stress and Fatigue; Heat, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to better understand ways that women and men differ physiologically, cognitively, physically, and cellularly to better prescribe helpful interventions that will prevent injury and risk of conditions like exertional heat illnesses or heatstroke. The main questions this project aims to answer are: 1. What is the relative stress contributing to performance differences between women and men during intense exercise in extremely hot and humid environments in response to exertional heat stress? 2. What is the relative contribution of responses in adipose tissue, cardiovascular tissue, gut microbiota, and musculoskeletal tissue on heat tolerance in women (vs. men) to exertional heat stress? 3. What is the impact of adding an antioxidant juice consumption regime and will it assist in enhancing performance during an acute bout of exercise-heat stress before and after heat acclimation? Subjects enrolled and approved for participation will perform: 1. a heat acclimation protocol which includes the completion of 5 days of prescribed exercise-heat exposure 2. two separate acute exercise-heat exposures for the assessment of thermotolerance and the investigation of potential enhancements in thermoregulatory performance that may occur after the completion of a 5-day heat acclimation protocol 3. a subset of subjects enrolled and approved for participation who opt in to antioxidant berry supplement consumption will either consume the active or placebo product throughout their participation.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Antioxidant Berry Supplementation
- OTHER Acute and Chronic Exercise-Heat Stress
- DIETARY_SUPPLEMENT Placebo (non-juice) Supplementation
Study Locations (1)
Connecticut
- Human Performance Laboratory at the University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-09-16 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05678738
The ClinicalTrials.gov registry entry for NCT05678738 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 47-participant average among 5 other Heat Stress trials with a reported enrollment target (130% higher). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heat Stress appearing as the primary indexed condition, and to 3 interventions - of which Antioxidant Berry Supplementation is the first listed.
NCT05678738 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05678738 about?
NCT05678738 is a clinical study titled "Acquiring and Targeting Heat Exposures Necessary for Action". The purpose of this research study is to better understand ways that women and men differ physiologically, cognitively, physically, and cellularly to better prescribe helpful interventions that will prevent injury and risk of conditions like exertional heat illnesses or heatstroke. The main question...
What is the current status of trial NCT05678738?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2021-09-16. Estimated completion is 2024-04-17.
What conditions does trial NCT05678738 study?
This clinical trial studies the following conditions: Heat Stress, Fatigue; Heat, Heat Intolerance.
What interventions are being tested in trial NCT05678738?
The interventions under investigation include: Antioxidant Berry Supplementation (DIETARY_SUPPLEMENT), Acute and Chronic Exercise-Heat Stress (OTHER), Placebo (non-juice) Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05678738?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05678738 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heat Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beat the Heat Boston
RECRUITING · NA
-
Effect of Rapid Heat Stress on Firefighters Musculoskeletal Injury Risk
RECRUITING · NA
-
Implementing an Intervention to Reduce Heat Stress and Chemical Exposures
ACTIVE NOT RECRUITING · NA
-
Aging, Beta Blockers, and Thermoregulatory Responses
RECRUITING · Phase 4
-
Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Older Adults
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.